Skye Bioscience, Inc. (SKYE) stock

SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30

$1.08+0.16 (+17.52%)

Close on Nov 12, 2026Market cap $38.26MP/E –Yield –

Skye Bioscience profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Skye Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?